ABSI absci.com Long-Term Loans to Capital Ratio

Brandmark of Absci Bio (ABSI)

The price chart (separate_debt_long_eq) for Absci (ABSI) illustrates the performance of the company developing protein therapeutics via generative AI. The current metric stands at 0.01, driven by massive software development costs that are limiting profit growth. Despite its status as an innovator trusted by pharmaceutical industry leaders, the business faces liquidity shortages and the uncertainty associated with the early stages of its technology implementation.

ABSI - Absci Corp. Long-Term Debt to Equity over the range 07/04/2022 - 10/28/2026

Metric breakdowns and analytics for Absci (ABSI)

- price and consensus price forecast:
Market Chart Absci Corp|ABSI - Consensus Target
- market capitalization data:
Market Value Absci Corporation|ABSI - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Absci|ABSI - Company Book Value|Market Cap to Net Assets Ratio absci.com|ABSI - Company Total Assets
- debt and liquidity data:
Debt to Capital Absci|ABSI - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio absci.com|ABSI - Company Aggregate Debts|Debts to Book Capitalization Absci Corporation
Summary company analysis:ABSI, Absci Corp
Core merchandise of Absci Corp

Sean McClain's ambitions to create AI platforms in bioengineering require a balance between expansion and financial stability. The long-term debt-to-equity ratio, which stands at 0.01, reflects the proportion of liabilities with a maturity of more than one year to shareholders' equity, allowing investors to assess the leverage level and long-term debt risks associated with scaling innovations at Absci (ABSI).

Analysis of competing companies

Ratio of Long-Term Indebtedness to Capital Veeva Systems (VEEV)|Long-Term Debt to Equity Ratio Doximity Corp|Long-Term Loans to Capital Ratio HealthEquity Building HQY|Long-Term Debt to Equity Ratio Waystar Holding Corp.|corvel.com - Long-Term Debt to Capital Coefficient|PRVA: Long-Term Debt to Equity|HURN - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital CERT|Omnicell Health (OMCL) - Long-Term Liabilities to Capital|Long-Term Debt to Capital GoodRx Holdings, Inc. (GDRX)|Long-Term Debt to Capital Ratio schrodinger.com|Long-Term Debt to Capital PHR|Long-Term Debt to Capital Omada Health, Inc. (OMDA)|Long-Term Debt to Capital Evolent EVH|HealthStream Learning - Long-Term Debt to Equity|Long-Term Debt to Equity DH (Definitive Healthcare)|CCSI - Ratio of Long-Term Indebtedness to Capital|AGL (agilon health) - Long-Term Debt to Capital|So-Young International Inc (SY) - Long-Term Debt to Equity Ratio|NRC: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital USA Mobility|Long-Term Debt to Capital OPRX|Long-Term Debt to Capital trubridge.com (TBRG)|Long-Term Debt to Capital Simulations Plus SLP|Sophia Genetics - Long-Term Debt to Equity|Long-Term Debt to Equity HCAT (Health Catalyst, Inc)|CCLD - Ratio of Long-Term Indebtedness to Capital|Research Solutions - Long-Term Debt to Capital|DLH Holdings (DLHC) - Ratio of Long-Term Indebtedness to Capital|ONMD: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Scienture Holdings (SCNX)|Long-Term Debt to Equity Ratio Healthcare Triangle Corp|Long-Term Loans to Capital Ratio ispecimen.com ISPC|Long-Term Debt to Equity Ratio Bullfrog AI|scworx.com - Long-Term Debt to Capital Coefficient|MSPR: Long-Term Debt to Equity|ICCT - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital MEDS|Orgenesis Corporation (ORGS) - Long-Term Liabilities to Capital|Long-Term Debt to Capital R1 RCM, Inc. (RCM)|Long-Term Debt to Capital Ratio sharecare.com|Long-Term Debt to Capital STRM|Long-Term Debt to Capital Syra Health Corp (SYRA)|Long-Term Debt to Capital Apollo Medical Holdings, Inc. AMEH|Model N Corporation - Long-Term Debt to Equity|Long-Term Debt to Equity NXGN (NextGen Healthcare)